{'fraction_non_alphanumeric': 0.032388663967611336, 'fraction_numerical': 0.0, 'mean_word_length': 4.983870967741935, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Inhibiting TNF to preserve lean body mass.


 Researchers suspect that tumor necrosis factor alpha (TNF), once thought to be a therapy for Kaposi's sarcoma (KS), plays a role in many AIDS-related complications--neurological difficulties, bone marrow suppression, the growth of KS lesions, and AIDS-related wasting. There are several therapies regarded as TNF reducers, including thalidomide and pentoxifylline, among others. Although many reduce TNF in the test tube, there are conflicting reports about whether they achieve this effect in the body. Since TNF can be undetectable in many tests, it may be important for researchers to evaluate closely the markers of immune and viral activity, rather than just TNF reduction for these drugs.
